[HTML][HTML] Targeted therapeutic options and future perspectives for HER2-positive breast cancer
J Wang, B Xu - Signal transduction and targeted therapy, 2019 - nature.com
Over the past 2 decades, there has been an extraordinary progress in the regimens
developed for the treatment of human epidermal growth factor receptor 2 (HER2)-positive …
developed for the treatment of human epidermal growth factor receptor 2 (HER2)-positive …
Targeted therapeutic options and future perspectives for HER2-positive breast cancer.
J Wang, B Xu - Signal Transduction & Targeted Therapy, 2019 - search.ebscohost.com
Over the past 2 decades, there has been an extraordinary progress in the regimens
developed for the treatment of human epidermal growth factor receptor 2 (HER2)-positive …
developed for the treatment of human epidermal growth factor receptor 2 (HER2)-positive …
Targeted therapeutic options and future perspectives for HER2-positive breast cancer
J Wang, B Xu - Signal Transduction and Targeted Therapy, 2019 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Over the past 2 decades, there has been an
extraordinary progress in the regimens developed for the treatment of human epidermal …
extraordinary progress in the regimens developed for the treatment of human epidermal …
[PDF][PDF] Targeted therapeutic options and future perspectives for HER2-positive breast cancer
2019 - scienceopen.com
Breast cancer is a heterogeneous disease, which can be divided into several subtypes with
diverse clinical characteristics, respective sensitivity to therapy, and different prognosis. 1, 2 …
diverse clinical characteristics, respective sensitivity to therapy, and different prognosis. 1, 2 …
Targeted therapeutic options and future perspectives for HER2-positive breast cancer.
J Wang, B Xu - Signal Transduction and Targeted Therapy, 2019 - europepmc.org
Over the past 2 decades, there has been an extraordinary progress in the regimens
developed for the treatment of human epidermal growth factor receptor 2 (HER2)-positive …
developed for the treatment of human epidermal growth factor receptor 2 (HER2)-positive …
Targeted therapeutic options and future perspectives for HER2-positive breast cancer
J Wang, B Xu - Signal Transduction and Targeted Therapy, 2019 - search.proquest.com
Over the past 2 decades, there has been an extraordinary progress in the regimens
developed for the treatment of human epidermal growth factor receptor 2 (HER2)-positive …
developed for the treatment of human epidermal growth factor receptor 2 (HER2)-positive …
[HTML][HTML] Targeted therapeutic options and future perspectives for HER2-positive breast cancer
J Wang, B Xu - Signal Transduction and Targeted Therapy, 2019 - ncbi.nlm.nih.gov
Over the past 2 decades, there has been an extraordinary progress in the regimens
developed for the treatment of human epidermal growth factor receptor 2 (HER2)-positive …
developed for the treatment of human epidermal growth factor receptor 2 (HER2)-positive …
Targeted therapeutic options and future perspectives for HER2-positive breast cancer
J Wang, B Xu - Signal transduction and targeted therapy, 2019 - pubmed.ncbi.nlm.nih.gov
Over the past 2 decades, there has been an extraordinary progress in the regimens
developed for the treatment of human epidermal growth factor receptor 2 (HER2)-positive …
developed for the treatment of human epidermal growth factor receptor 2 (HER2)-positive …
Targeted therapeutic options and future perspectives for HER2-positive breast cancer.
J Wang, B Xu - Signal Transduction and Targeted Therapy, 2019 - europepmc.org
Over the past 2 decades, there has been an extraordinary progress in the regimens
developed for the treatment of human epidermal growth factor receptor 2 (HER2)-positive …
developed for the treatment of human epidermal growth factor receptor 2 (HER2)-positive …